April 2025 | Episode Title: Practice Revolution? The Rise in the Independent Practices
As health system consolidation accelerates, a growing number of physicians are re-evaluating their employment models—and some are choosing to return to independent practice. But what does this shift mean for biopharma?
In this episode of 81qd Tools of Engagement, host Susan Abedi speaks with Dr. Jasen Gundersen, cardiologist, CEO of CardioOne, and board member of AIMPA, to discuss how the rise of independent practices is creating new dynamics in healthcare engagement—and new opportunities for biopharma.
This conversation offers practical insights for commercial, medical affairs, and market access leaders seeking to adapt field strategy, enhance engagement, and support HCPs operating outside of large systems.
Key Takeaways:
- Faster Access & Decision-Making: Independent physicians can engage more quickly and flexibly—without layers of system-level gatekeeping.
- New Channels for Clinical Research & Innovation: Independent practices are increasingly open to clinical trial participation and digital health pilots.
- Tailored Support Wins: Operational support, patient education tools, and flexible value messaging are key to building trust and differentiation.
- Diverse Populations, Local Impact: These practices often serve underserved or non-urban populations that are harder to reach through system-based strategies.
Watch the Full Episode
Purpose-Built Data Analytics Tools
Acuity
Acuity programmatically mines data related to digital online behavior, conference speaking engagements, healthcare congresses, professional association leadership positions, guideline development committee involvement, publications and editorial responsibilities with select journals.
Talk to an Expert
To discover how 81qd’s expertise can support your initiatives in the rare disease space, request a demo or reach out to our team.